AbCellera Reports Positive Phase 2 Results for ABCL635
VANCOUVER, British Columbia, August 10, 2026 AbCellera Biologics Inc. announced positive topline results from the Phase 2 portion of...
Vasomotor Symptoms
Advertisement
AbCellera to Announce ABCL635 Phase 2 Results
VANCOUVER, British Columbia, August 7, 2026 AbCellera announced that it will release top-line results from the Phase 2 clinical...
Astellas Advances Menopause Drug Toward Japan Approval
TOKYO, August 7, 2026 Astellas Pharma announced the submission of a New Drug Application (NDA) to Japan’s Ministry of...
Noema Pharma AG Shows Strong Phase 2a Menopause Results
BASEL, Switzerland and BOSTON, MA, May 1, 2026 Noema Pharma AG announced the presentation of positive Phase 2a clinical...
Bayer’s Elinzanetant Secures CHMP Backing for Menopause Therapy
Berlin, Germany – September 19, 2025 — Bayer announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products...
Advertisement
